Searchable abstracts of presentations at key conferences in endocrinology

ea0022p175 | Clinical case reports and clinical practice | ECE2010

Fenofibrate-induced rhabdomyolysis and acute renal failure in patient with occult hypothyroidism

Karbek Basak , Kadi Ragip , Goksu Ugur Alp , Arik Nurol

Rhabdomyolysis is a syndrome characterized by muscle necrosis and the release of intracelluler muscle contents into systemic circulation. It can became a life-threatening disorder when complicated by acute tubuler necrosis and renal failure. Fenofibrate, a fibric acid derivate, is used to treat diabetic dyslipidemia, hypertriglyceridemia and combined hyperlipidemia alone or in combination with statins. Rhabdomyolysis associated with fenofibrate is extremely rare. In nearly all...